Literature DB >> 1664984

Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential.

J W Sixbey1, P Shirley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1664984     DOI： 10.1007/bf00201467

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  68 in total

1.  Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

Authors:  S D Abbot; M Rowe; K Cadwallader; A Ricksten; J Gordon; F Wang; L Rymo; A B Rickinson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

Authors:  M Rowe; L S Young; K Cadwallader; L Petti; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.

Authors:  C Rooney; N Taylor; J Countryman; H Jenson; J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

Review 5.  Viral interference-dominance of mutant viruses over wild-type virus in mixed infections.

Authors:  P Whitaker-Dowling; J S Youngner
Journal:  Microbiol Rev       Date:  1987-06

6.  Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.

Authors:  M S Cho; L Gissmann; S D Hayward
Journal:  Virology       Date:  1984-08       Impact factor: 3.616

7.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.

Authors:  W King; T Dambaugh; M Heller; J Dowling; E Kieff
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

10.  A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.

Authors:  J W Sixbey; P Shirley; M Sloas; N Raab-Traub; V Israele
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226
View more
  1 in total

1.  Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins.

Authors:  David S Bellows; Melanie Howell; Colin Pearson; Sheila A Hazlewood; J Marie Hardwick
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.